Urbanucci A - Search Results

1

AR and ERG drive the expression of prostate cancer specific long noncoding RNAs.

Kohvakka A, Sattari M, Shcherban A, Annala M, Urbanucci A, Kesseli J, Tammela TLJ, Kivinummi K, Latonen L, Nykter M, Visakorpi T. Kohvakka A, et al. Among authors: urbanucci a. Oncogene. 2020 Jul;39(30):5241-5251. doi: 10.1038/s41388-020-1365-6. Epub 2020 Jun 17. Oncogene. 2020. PMID: 32555329

2

Androgen regulation of the androgen receptor coregulators.

Urbanucci A, Waltering KK, Suikki HE, Helenius MA, Visakorpi T. Urbanucci A, et al. BMC Cancer. 2008 Aug 1;8:219. doi: 10.1186/1471-2407-8-219. BMC Cancer. 2008. PMID: 18673534 Free PMC article.

3

Androgen regulation of micro-RNAs in prostate cancer.

Waltering KK, Porkka KP, Jalava SE, Urbanucci A, Kohonen PJ, Latonen LM, Kallioniemi OP, Jenster G, Visakorpi T. Waltering KK, et al. Among authors: urbanucci a. Prostate. 2011 May;71(6):604-14. doi: 10.1002/pros.21276. Epub 2010 Oct 13. Prostate. 2011. PMID: 20945501

4

Overexpression of androgen receptor enhances the binding of the receptor to the chromatin in prostate cancer.

Urbanucci A, Sahu B, Seppälä J, Larjo A, Latonen LM, Waltering KK, Tammela TL, Vessella RL, Lähdesmäki H, Jänne OA, Visakorpi T. Urbanucci A, et al. Oncogene. 2012 Apr 26;31(17):2153-63. doi: 10.1038/onc.2011.401. Epub 2011 Sep 12. Oncogene. 2012. PMID: 21909140

5

Androgen receptor overexpression alters binding dynamics of the receptor to chromatin and chromatin structure.

Urbanucci A, Marttila S, Jänne OA, Visakorpi T. Urbanucci A, et al. Prostate. 2012 Aug 1;72(11):1223-32. doi: 10.1002/pros.22473. Epub 2011 Dec 27. Prostate. 2012. PMID: 22212979

6

Androgen receptor (AR) aberrations in castration-resistant prostate cancer.

Waltering KK, Urbanucci A, Visakorpi T. Waltering KK, et al. Among authors: urbanucci a. Mol Cell Endocrinol. 2012 Sep 5;360(1-2):38-43. doi: 10.1016/j.mce.2011.12.019. Epub 2012 Jan 8. Mol Cell Endocrinol. 2012. PMID: 22245783 Review.

7

Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.

Jalava SE, Urbanucci A, Latonen L, Waltering KK, Sahu B, Jänne OA, Seppälä J, Lähdesmäki H, Tammela TL, Visakorpi T. Jalava SE, et al. Among authors: urbanucci a. Oncogene. 2012 Oct 11;31(41):4460-71. doi: 10.1038/onc.2011.624. Epub 2012 Jan 23. Oncogene. 2012. PMID: 22266859

8

Chemical castration and anti-androgens induce differential gene expression in prostate cancer.

Lehmusvaara S, Erkkilä T, Urbanucci A, Waltering K, Seppälä J, Larjo A, Tuominen VJ, Isola J, Kujala P, Lähdesmäki H, Kaipia A, Tammela TLj, Visakorpi T. Lehmusvaara S, et al. Among authors: urbanucci a. J Pathol. 2012 Jul;227(3):336-45. doi: 10.1002/path.4027. Epub 2012 May 8. J Pathol. 2012. PMID: 22431170 Clinical Trial.

9

Goserelin and bicalutamide treatments alter the expression of microRNAs in the prostate.

Lehmusvaara S, Erkkilä T, Urbanucci A, Jalava S, Seppälä J, Kaipia A, Kujala P, Lähdesmäki H, Tammela TL, Visakorpi T. Lehmusvaara S, et al. Among authors: urbanucci a. Prostate. 2013 Jan;73(1):101-12. doi: 10.1002/pros.22545. Epub 2012 Jun 5. Prostate. 2013. PMID: 22674191 Clinical Trial.

10

Myc-dependent purine biosynthesis affects nucleolar stress and therapy response in prostate cancer.

Barfeld SJ, Fazli L, Persson M, Marjavaara L, Urbanucci A, Kaukoniemi KM, Rennie PS, Ceder Y, Chabes A, Visakorpi T, Mills IG. Barfeld SJ, et al. Among authors: urbanucci a. Oncotarget. 2015 May 20;6(14):12587-602. doi: 10.18632/oncotarget.3494. Oncotarget. 2015. PMID: 25869206 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters